The N17 Domain of Huntingtin As a Multifaceted Player in Huntington's Disease

Overview

Journal Front Mol Biosci

Date 2025 Jan 23

PMID 39845903

Authors

Hyunju Cho

Affiliations

Soon will be listed here.

Abstract

Huntington's disease (HD) is primarily caused by the aberrant aggregation of the N-terminal exon 1 fragment of mutant huntingtin protein (mHttex1) with expanded polyglutamine (polyQ) repeats in neurons. The first 17 amino acids of the N-terminus of Httex1 (N17 domain) immediately preceding the polyQ repeat domain are evolutionarily conserved across vertebrates and play multifaceted roles in the pathogenesis of HD. Due to its amphipathic helical properties, the N17 domain, both alone and when membrane-associated, promotes mHttEx1 aggregation. Diverse post-translational modifications (PTMs) in the N17 domain alter the aggregation state, thus modulating the cellular toxicity of mHttex1. Furthermore, the N17 domain serves as a nuclear export signal (NES) and mediates the cytoplasmic localization of mHttex1. This review summarizes the four main roles of the N17 domain in regulating HD pathology and discusses potential therapeutic approaches targeting this N17 domain to mitigate HD progression.

References

Liu K, Shyu Y, Barbaro B, Lin Y, Chern Y, Thompson L . Disruption of the nuclear membrane by perinuclear inclusions of mutant huntingtin causes cell-cycle re-entry and striatal cell death in mouse and cell models of Huntington's disease. Hum Mol Genet. 2014; 24(6):1602-16. PMC: 4381756. DOI: 10.1093/hmg/ddu574. View

Thompson L, Aiken C, Kaltenbach L, Agrawal N, Illes K, Khoshnan A . IKK phosphorylates Huntingtin and targets it for degradation by the proteasome and lysosome. J Cell Biol. 2009; 187(7):1083-99. PMC: 2806289. DOI: 10.1083/jcb.200909067. View

Zheng Z, Li A, Holmes B, Marasa J, Diamond M . An N-terminal nuclear export signal regulates trafficking and aggregation of Huntingtin (Htt) protein exon 1. J Biol Chem. 2013; 288(9):6063-71. PMC: 3585045. DOI: 10.1074/jbc.M112.413575. View

Gusella J, Macdonald M . Molecular genetics: unmasking polyglutamine triggers in neurodegenerative disease. Nat Rev Neurosci. 2001; 1(2):109-15. DOI: 10.1038/35039051. View

Kegel K, Kim M, Sapp E, McIntyre C, Castano J, Aronin N . Huntingtin expression stimulates endosomal-lysosomal activity, endosome tubulation, and autophagy. J Neurosci. 2000; 20(19):7268-78. PMC: 6772788. View

Panov A, Gutekunst C, Leavitt B, Hayden M, Burke J, Strittmatter W . Early mitochondrial calcium defects in Huntington's disease are a direct effect of polyglutamines. Nat Neurosci. 2002; 5(8):731-6. DOI: 10.1038/nn884. View

Lunkes A, Lindenberg K, Ben-Haiem L, Weber C, Devys D, Landwehrmeyer G . Proteases acting on mutant huntingtin generate cleaved products that differentially build up cytoplasmic and nuclear inclusions. Mol Cell. 2002; 10(2):259-69. DOI: 10.1016/s1097-2765(02)00602-0. View

Ramirez-Jarquin U, Sharma M, Zhou W, Shahani N, Subramaniam S . Deletion of SUMO1 attenuates behavioral and anatomical deficits by regulating autophagic activities in Huntington disease. Proc Natl Acad Sci U S A. 2022; 119(5). PMC: 8812691. DOI: 10.1073/pnas.2107187119. View

DiFiglia M, Sapp E, Chase K, Davies S, Bates G, Vonsattel J . Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. Science. 1997; 277(5334):1990-3. DOI: 10.1126/science.277.5334.1990. View

10.

Veldman M, Rios-Galdamez Y, Lu X, Gu X, Qin W, Li S . The N17 domain mitigates nuclear toxicity in a novel zebrafish Huntington's disease model. Mol Neurodegener. 2015; 10:67. PMC: 4673728. DOI: 10.1186/s13024-015-0063-2. View

11.

Sathasivam K, Neueder A, Gipson T, Landles C, Benjamin A, Bondulich M . Aberrant splicing of HTT generates the pathogenic exon 1 protein in Huntington disease. Proc Natl Acad Sci U S A. 2013; 110(6):2366-70. PMC: 3568346. DOI: 10.1073/pnas.1221891110. View

12.

Vieweg S, Mahul-Mellier A, Ruggeri F, Riguet N, DeGuire S, Chiki A . The Nt17 Domain and its Helical Conformation Regulate the Aggregation, Cellular Properties and Neurotoxicity of Mutant Huntingtin Exon 1. J Mol Biol. 2021; 433(21):167222. DOI: 10.1016/j.jmb.2021.167222. View

13.

Mayer M, Gierasch L . Recent advances in the structural and mechanistic aspects of Hsp70 molecular chaperones. J Biol Chem. 2018; 294(6):2085-2097. PMC: 6369304. DOI: 10.1074/jbc.REV118.002810. View

14.

Cariulo C, Azzollini L, Verani M, Martufi P, Boggio R, Chiki A . Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation. Proc Natl Acad Sci U S A. 2017; 114(50):E10809-E10818. PMC: 5740681. DOI: 10.1073/pnas.1705372114. View

15.

Michalek M, Salnikov E, Bechinger B . Structure and topology of the huntingtin 1-17 membrane anchor by a combined solution and solid-state NMR approach. Biophys J. 2013; 105(3):699-710. PMC: 3736738. DOI: 10.1016/j.bpj.2013.06.030. View

16.

Kim Y, Yi Y, Sapp E, Wang Y, Cuiffo B, Kegel K . Caspase 3-cleaved N-terminal fragments of wild-type and mutant huntingtin are present in normal and Huntington's disease brains, associate with membranes, and undergo calpain-dependent proteolysis. Proc Natl Acad Sci U S A. 2001; 98(22):12784-9. PMC: 60131. DOI: 10.1073/pnas.221451398. View

17.

Lecerf J, Shirley T, Zhu Q, Kazantsev A, Amersdorfer P, Housman D . Human single-chain Fv intrabodies counteract in situ huntingtin aggregation in cellular models of Huntington's disease. Proc Natl Acad Sci U S A. 2001; 98(8):4764-9. PMC: 31908. DOI: 10.1073/pnas.071058398. View

18.

Gu X, Cantle J, Greiner E, Lee C, Barth A, Gao F . N17 Modifies mutant Huntingtin nuclear pathogenesis and severity of disease in HD BAC transgenic mice. Neuron. 2015; 85(4):726-41. PMC: 4386927. DOI: 10.1016/j.neuron.2015.01.008. View

19.

Atwal R, Desmond C, Caron N, Maiuri T, Xia J, Sipione S . Kinase inhibitors modulate huntingtin cell localization and toxicity. Nat Chem Biol. 2011; 7(7):453-60. DOI: 10.1038/nchembio.582. View

20.

van Meer G, Voelker D, Feigenson G . Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol. 2008; 9(2):112-24. PMC: 2642958. DOI: 10.1038/nrm2330. View